GOLDMAN SACHS GROUP INC - EFFECTOR THERAPEUTICS INC ownership

EFFECTOR THERAPEUTICS INC's ticker is and the CUSIP is 28202V116. A total of 23 filers reported holding EFFECTOR THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of EFFECTOR THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$757
-99.1%
630,5390.0%0.00%
Q1 2024$85,186
+87.4%
630,5390.0%0.00%
Q4 2023$45,462
-5.1%
630,5390.0%0.00%
Q3 2023$47,921
-44.5%
630,5390.0%0.00%
Q2 2023$86,384
+82.7%
630,5390.0%0.00%
Q1 2023$47,290
-3.2%
630,5390.0%0.00%
Q4 2022$48,867
+38077.3%
630,5390.0%0.00%
Q3 2022$128
+26.7%
630,539
+24.7%
0.00%
Q2 2022$101
-99.9%
505,5390.0%0.00%
Q1 2022$175,000
-60.7%
505,5390.0%0.00%
Q4 2021$445,000
-45.2%
505,539
-0.4%
0.00%
Q3 2021$812,000507,7840.00%
Other shareholders
EFFECTOR THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
MARINER INVESTMENT GROUP LLC 22,935$37,0000.10%
ARISTEIA CAPITAL, L.L.C. 1,750,000$2,844,0000.05%
Monashee Investment Management LLC 133,332$213,0000.04%
MMCAP International Inc. SPC 150,867$241,0000.02%
Alpine Global Management, LLC 40,450$65,0000.02%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 323,245$517,0000.01%
CVI Holdings, LLC 88,462$144,0000.01%
LITTLEJOHN & CO LLC 16,666$27,0000.01%
WHITEBOX ADVISORS LLC 218,447$350,0000.01%
EQUITEC PROPRIETARY MARKETS, LLC 12,700$20,0000.00%
View complete list of EFFECTOR THERAPEUTICS INC shareholders